Company / PP&E per Share
Ginkgo Bioworks Holdings, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.09
FY2025
5-year range
$0.10 / $4.07
FY2021-FY2025
Trend
-24.2%
vs FY2024
Sector context
#26 of 193
Health Care
What the data says
Ginkgo Bioworks Holdings, Inc.'s pp&e per share of $3.09 is higher than 87% of companies in the Health Care sector (FY2025). PP&E per Share has fluctuated over the past 6 years, ranging from $0.10 in FY2020 to $4.07 in FY2024.
Based on SEC 10-K filings.
3.09 in FY2025 with a 5-year CAGR of +100.5%. Top quartile in the Health Care sector.
Improved from $0.10 to $3.09 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +150.9%
- 5-Year CAGR
- +100.5%
- 10-Year CAGR
- -
Sector benchmark
-83.5% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 24.2% year-over-year.
- Ranks #26 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.09 | -24.2% |
| FY2024 | $4.07 | +3993.5% |
| FY2023 | $0.10 | -49.1% |
| FY2022 | $0.20 | +72.7% |
| FY2021 | $0.11 | +18.8% |
| FY2020 | $0.10 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026